ANTICIPATING GN-TECH'S STRATEGY After clearing up contract problems with Brixmortar and setting a strategy with MDCO Inc., ELX Labs is now ready to confront the pricing issue with GN-Tech directly. The first thing you and your team need to figure out is how GN-Tech would price its biosimilar drug in relation to ELX Labs' drug Minichol. You and your team come up with a few possibilities, and you have to decide which you think is GN-Tech's most likely move. Which is it? Select an option from the choices below. GN-Tech will try to match the price of Minichol. GN-Tech will price its drug lower than Minichol. GN-Tech will price its drug higher than Minichol